申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US04482547A1
公开(公告)日:1984-11-13
This invention relates to substituted-1,3,4-benzotriazepines of the formula ##STR1## wherein X and Y are each independently hydrogen, lower alkyl, halogen, lower alkoxy, nitro and hydroxyl; R.sub.1 and R.sub.3 are each independently hydrogen or alkyl; R.sub.2 is hydrogen, lower alkyl, cycloalkyl lower alkyl, phenyl, Ar lower alkyl, hydroxyl and sulfhydryl; m and n are each independently integers of 0 or 1 and when m is 0, n is 1 and vice-versa; and p and q are independently integers of 1 or 2. Also included in the invention are the substituted-1,3,4-benzotriazepine derivatives of tautomeric form when the substituent for R.sub.1 and/or R.sub.3 in the above formula is hydrogen. The compound of this invention may be used as antihypertensive agents.
这项发明涉及式 ##STR1## 的取代-1,3,4-苯并三氮杂环己烷,其中 X 和 Y 各自独立地是氢、较低的烷基、卤素、较低的烷氧基、硝基和羟基;R.sub.1 和 R.sub.3 各自独立地是氢或烷基;R.sub.2 是氢、较低的烷基、环烷基较低的烷基、苯基、Ar 较低的烷基、羟基和硫醇;m 和 n 各自独立地是 0 或 1 的整数,当 m 为 0 时,n 为 1,反之亦然;p 和 q 各自独立地是 1 或 2 的整数。该发明还包括上述式中 R.sub.1 和/或 R.sub.3 的取代物为氢时的互变异构形式的取代-1,3,4-苯并三氮杂环己烷衍生物。本发明的化合物可用作降压药。